Synthetic Genomics announceda multi-year research and development agreement with Lung Biotechnology to develop humanized pig organs using synthetic genomic advances. The collaboration will focus upon developing organs for human patients in need of transplantation, with an initial focus on lung diseases.
In the United States alone, about 400,000 people die annually from various forms of lung disease including cancer. 2,000 people are saved with a lung transplant and about the same number are added to the transplant wait list annually. 99% of deaths due to lung failure are unavoidable because of the shortage of transplantable human lungs.
Previous attempts to use animal organs have failed due to genomic incompatibilities, especially with respect to immune and coagulation systems. The collaboration between Synthetic Genomics and Lung Biotechnology aims to eliminate these genomic incompatibilities.
Using DNA design, DNA synthesis and genome editing, as well as genome modification tools,
will develop engineered primary pig cells with modified genomes. This work will entail modification of a substantial number of genes at an unprecedented scale and efficiency. United Therapeutics, parent company of Lung Biotechnology, will leverage its xenotransplantation expertise to implant these engineered cells, generating pig embryos which develop and are born with humanized lungs. The companies are striving to develop these new methods and advances to create organs that are safe and effective for use in humans.
Lung Biotechnology made a $50,000,000 investment in Synthetic Genomics.
"We believe that our proprietary synthetic genomic tools and technologies, coupled with United Therapeutics' knowledge and advances in regenerative medicine technologies and treatment of lung diseases, should enable us to develop humanized pig organs for safe and effective transplant into humans. We believe this is one of the most exciting and important programs ever undertaken in modern medical science," said J. Craig Venter, Ph.D., Founder and CEO, SGI.
- PHYSICAL SCIENCES
- EARTH SCIENCES
- LIFE SCIENCES
- SOCIAL SCIENCES
Subscribe to the newsletter
Stay in touch with the scientific world!
Know Science And Want To Write?
- Wait, Let's Not Be In Such A Rush To Go Multiplanetary Or Interstellar - A Comment On Elon Musk's Vision
- Petition To Youtube To Halt Ads On Doomsday Videos - They Make The Vulnerable Suicidal
- Paleo: In A Clinical Trial, Bread Made With Ancient Grains Could Benefit Heart Health
- Hubble Spots Europa Geysers Again - How They Did It - And What Next? Flyby? Lander?
- Why Psychology Lost Its Soul - Science Replaced It
- Chatelperronian Hominins: Disputed Neanderthal Region Confirmed In France
- No Go Area! What? What is that?
- "Oh, sorry to hear that, I hear this so often. Basically it's like propoganda I think. Propoganda..."
- "Hi mr walker... lately i havent been able to eat or drink.. and if i do sleep its during the whole..."
- "Right, California did, but prior to that there were schools in Marin with only 25% vaccination..."
- "I don't just mean Trump - I mean Paul, Fiorina, Christie, and to the medical community's horror..."
- "I like how Farid's lifestyle changed so that he could identify in a way that he wanted people to..."
- Is Parenting Kids of Human and Canine Persuasion the Same? Yes!
- Diabetes: MiniMed 670G Hybrid Closed-Loop Insulin System Is A Waypoint To An Artificial Pancreas
- Celebrate Oktoberfest with Beer Chemistry
- Littlest Consumers Doing Well, Nutrition-wise
- Herpes Vaccine Update: Exciting News, But Don't Throw Away Condoms Just Yet
- Ben & Jerry’s Asks Us to Take Big Lick of Fear & Hype
- Antipsychotic medications linked to increased risk of pneumonia in persons with Alzheimer's disease
- Multiple sclerosis misdiagnosis shows need for improved education of clinicians
- Brown adipose tissue can secrete factors that activate fat and carbohydrate metabolism
- Therapeutic Gene Delivery for Inherited Retinal Degeneration in Children
- Molecular atlas of the pancreas